SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hikal informs about disclosure

16 Jul 2025 Evaluate
Hikal has informed that as per disclosure under Regulation 30, 30A read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company received intimation from Sameer Trust (Entity of Promoter group of the Company) dated July 15, 2025 about initiation of process of dissolution of Sameer Trust and transfer of shares to Sameer Jai. Hiremath, being the beneficiary of the Trust and one of the existing promoters of the company. Enclosed the pre and post shareholding after giving effect to the transfer of shares from Sameer Trust to Sameer Jai Hiremath, there is no change in the aggregate promoter shareholding.

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

187.05 -2.40 (-1.27%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×